Connect to share and comment
Following is a summary of current health news briefs.
Creditors probe meningitis-linked pharmacy owners' pay
BOSTON (Reuters) - Creditors of the bankrupt pharmacy linked to a deadly U.S. meningitis outbreak are investigating $16 million in salary and shareholder distributions made to company owners in 2012, a lawyer for the group said on Tuesday. Some of the transfers from the New England Compounding Center, which had 2012 sales of $32.4 million, followed the discovery last fall of the meningitis outbreak that has killed 44 people, according to documents filed late on Friday.
Vanda sleep drug effective in second late-stage trial 2013-01-23T124913Z_1_BRE90M0NQ_RTROPTC_0_US-VANDA-TRIAL-SLEEPDR UG.XML () -
Novartis expects sales to grow from 2014
ZURICH (Reuters) - Novartis <NOVN.VX> expects sales to grow in the mid-single digits from 2014 once it has absorbed the full impact of competition from cheaper drugs, and said its long-standing chairman and former Chief Executive would step down next month. The Basel-based group guided investors to expect a mid-single digit decline in its core operating margin on a constant currency basis in 2013, as competition from generic copies knocks $3.5 billion off sales.
J&J mulls sale of diagnostics unit
2013-01-22T193538Z_8_BRE90L0H6_RTROPTC_0_US-JJ-RESULTS.XML () -
U.S. top court rejects hospitals' Medicare claims suit 2013-01-22T214130Z_2_BRE90L0ZG_RTROPTC_0_US-USA-COURT-MEDICARE. XML () -
Limited impact on child abuse from visits, intervention: study
2013-01-23T030321Z_2_BRE90M038_RTROPTC_0_US-CHILDABUSE.XML () -
Celgene's Abraxane increases survival in pancreatic cancer 2013-01-22T230104Z_1_BRE90L14P_RTROPTC_0_US-CELGENE-CANCER.XML () -
Lilly stomach cancer drug extends survival vs placebo 2013-01-23T022455Z_1_BRE90M04F_RTROPTC_0_US-LILLY-CANCER.XML () -
Allergan aims to widen migraine treatment with MAP Pharma buy 2013-01-23T031422Z_3_BRE90M03C_RTROPTC_0_US-MAPPHARMA-ALLERGEN. XML () -
Poor U.S. hospitals likeliest to pay readmission fine
NEW YORK (Reuters Health) - Large teaching hospitals and hospitals that primarily provide care to poor and uninsured patients are most likely to lose federal money under the U.S. government's plan to improve quality by tying payments to readmissions, according to new research. "The concern has been raised that when these penalties did come out, they would unfairly target the hospitals that treat the poorest and most complex patients," said Dr. Karen Joynt, the study's lead author from the Harvard School of Public Health in Boston.